GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DSwiss Inc (OTCPK:DQWS) » Definitions » ROCE %

DQWS (DSwiss) ROCE % : -83.68% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is DSwiss ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DSwiss's annualized ROCE % for the quarter that ended in Sep. 2024 was -83.68%.


DSwiss ROCE % Historical Data

The historical data trend for DSwiss's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DSwiss ROCE % Chart

DSwiss Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only -250.43 - 217.02 2.53 -44.02

DSwiss Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.27 -256.16 442.24 40.63 -83.68

DSwiss ROCE % Calculation

DSwiss's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-0.046/( ( (0.382 - 0.245) + (0.367 - 0.295) )/ 2 )
=-0.046/( (0.137+0.072)/ 2 )
=-0.046/0.1045
=-44.02 %

DSwiss's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=-0.2/( ( (0.571 - 0.309) + (0.817 - 0.601) )/ 2 )
=-0.2/( ( 0.262 + 0.216 )/ 2 )
=-0.2/0.239
=-83.68 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DSwiss  (OTCPK:DQWS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


DSwiss ROCE % Related Terms

Thank you for viewing the detailed overview of DSwiss's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


DSwiss Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Jalan Kerinchi, Avenue 3, Bangsar South, Tower A, Vertical Business Suite, Unit 18-11, 18-12 and 18-01, Kuala Lumpur, SGR, MYS, 59200
DSwiss Inc is a biotech-nutraceutical company intended to manufacture nutraceutical, skincare, personal care products, and pet supplements. The company is involved with original equipment manufacturers (OEM), original design manufacturers (ODM), and original brand manufacturers (OBM) and manages custom formulation of scientifically approved and naturally effective, sourcing raw materials, production, quality control, stability, and safety test, clinical testing by third-party labs, packaging and shipping including import and export, all licenses needed, enabling end users to achieve health improvement, slimming, anti-aging, and beauty effects.
Executives
Greenpro Venture Capital Ltd 10 percent owner SUITE 2201, 22/F MALAYSIA BUILDING,, 50 GLOUCESTER ROAD, WANCHA K3 00000
Wing Wai Heung director RM 405, 4/F ENERGY PLAZA,, TSIM SHA TSUI EAST K3 000000
Ming Chia Leong director, 10 percent owner, officer: CEO B-12-11, PRIMA AVENUE,, THE TUBE, JALAN PJU 1/39,DATARAN PRIMA,, PETALING JAYA,SELANGOR N8 47301
Lee Yee Chua director, officer: CFO B-12-11, PRIMA AVENUE,, THE TUBE, JALAN PJU 1/39,DATARAN PRIMA,, PETALING JAYA,SELANGOR N8 47301
Zhee Long Cheng director B-12-11, PRIMA AVENUE,, THE TUBE, JALAN PJU 1/39,DATARAN PRIMA,, PETALING JAYA,SELANGOR N8 47301